Fresenius confirms it’s weighing a bid for generic drugmaker Akorn https://t.co/ukTMzQ6H7p via @FT — The Propell Group (@ThePropellGroup) April 8, 2017 #healthtech
Hive wants to automate crop-dusting for China’s farmers https://t.co/llN2xPS5vh — The Propell Group (@ThePropellGroup) April 8, 2017 #healthtech
Holmusk collaborates with Singapore to manage cardio diseases – BioSpectrum Asia https://t.co/uQNfNOd3g1 — The Propell Group (@ThePropellGroup) April 8, 2017 #healthtech
The State Of Synthetic Biology: Investors Placing Bets In Food, Biofuel, Healthcare, And More https://t.co/wEblcTDVFc — The Propell Group (@ThePropellGroup) April 7, 2017 #healthtech
Dubai 100 launches European Bootcamp in London – as Dubai Pitch Day draws near https://t.co/mvVsGzYnhl — The Propell Group (@ThePropellGroup) April 7, 2017 #healthtech
FDA clears consumer genetic tests in victory for 23andMe https://t.co/6W0mQ0bLNu via @FT — The Propell Group (@ThePropellGroup) April 7, 2017 #healthtech
Q1 2017: Business as usual for digital health | Rock Health https://t.co/rPVezFCwT3 — The Propell Group (@ThePropellGroup) April 6, 2017 #healthtech
Q1 2017: Business as usual for digital health | Rock Health https://t.co/ZGdi4xX4KK — The Propell Group (@ThePropellGroup) April 6, 2017 #healthtech
On The Record: Investors, Execs, and Clinicians On How EHR/EMR Will Drive The Future Of Medical Treatment https://t.co/48EczNS6MW — The Propell Group (@ThePropellGroup) April 6, 2017 #healthtech
Zuellig Pharma investing S$50m in first innovation centre in Singapore – Channel NewsAsia https://t.co/RCz4wm9Vwh — The Propell Group (@ThePropellGroup) April 6, 2017 #healthtech